NCT07148193View on ClinicalTrials.gov

Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)

Not yet recruitingOBSERVATIONAL
Enrollment

1,600

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
SarcomaSurvivorshipQuality of Life (QOL)Medical Care
Interventions
OTHER

No intervention (observational study)

No intervention (observational study)

Trial Locations (5)

Unknown

Technical University Dresden, Dresden

University Hospital Essen, Essen

NCT Heidelberg, Heidelberg

Sarcoma Center Mannheim, Mannheim

Deutsche Sarkom-Stiftung, Wölfersheim

All Listed Sponsors
collaborator

German Sarcoma Foundation (DSS)

UNKNOWN

collaborator

German Cancer Research Center

OTHER

collaborator

Universitätsmedizin Mannheim

OTHER

collaborator

University Hospital, Essen

OTHER

collaborator

National Centre for Tumor Diseases Heidelberg

UNKNOWN

lead

Technische Universität Dresden

OTHER

NCT07148193 - Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+) | Biotech Hunter | Biotech Hunter